Keyphrases
Chilean
100%
Latin American
100%
Mexican
100%
Retrospective Analysis
100%
Tumor Registry
100%
GI Stromal Tumor
100%
Latin America (LATAM)
25%
Clinical Characteristics
25%
Incidence Rate
25%
Tumor Incidence
25%
Stage at Diagnosis
25%
Chile
12%
South America
12%
Mexico
12%
Europe
12%
Malignancy
12%
Immunohistochemistry
12%
Salud
12%
Survival Rate
12%
CD117
12%
Mitotic Index
12%
Progression-free Survival
12%
Overall Survival
12%
Poor Prognosis
12%
North America
12%
Highly Heterogeneous
12%
Datos
12%
Histopathological Features
12%
Malignant Potential
12%
Age-stage
12%
Tumor Size
12%
Overall Survival Time
12%
Regional Disease
12%
Recurrence Risk
12%
High-risk of Recurrence
12%
Localized Disease
12%
Collaborative Efforts
12%
Index Size
12%
Primary Tumor Location
12%
Mexican Patients
12%
Distant Disease
12%
Mathematics
Retrospective Analysis
100%
Incidence Rate
100%
Survival Time
50%
Tumor Size
50%
Observed Difference
50%
Survival Rate
50%
Medicine and Dentistry
Stromal Tumor
100%
Prevalence
50%
Recurrent Disease
37%
Cancer Incidence
25%
Overall Survival
25%
Disease
12%
Neoplasm
12%
Cancer
12%
Survival Rate
12%
Immunohistochemistry
12%
Mitotic Index
12%
Progression Free Survival
12%
Survival Time
12%
Primary Tumor
12%
Treatment of Localized Disease
12%
Immunology and Microbiology
Prevalence
100%
Overall Survival
50%
Cancer Incidence
50%
CD117
25%
Mitosis Index
25%
Survival Rate
25%
Survival Time
25%
Progression Free Survival
25%
Tumor Volume
25%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Prevalence
57%
Recurrent Disease
42%
Disease
28%
Overall Survival
28%
Cancer Incidence
28%
Progression Free Survival
14%
Survival Rate
14%
Survival Time
14%
Primary Tumor
14%